食管鳞状细胞癌的肿瘤血管生成机制

国际肿瘤学杂志››2016,Vol. 43››Issue (6): 465-467.doi:10.3760/cma.j.issn.1673-422X.2016.06.018

食管鳞状细胞癌的肿瘤血管生成机制

吕雅静，王伟，季楚舒，胡冰

230001合肥，安徽医科大学附属省立医院肿瘤化疗科

收稿日期:2015-11-18出版日期:2016-06-08发布日期:2016-04-27
通讯作者:胡冰 E-mail:hubin3756@sina.com
基金资助:

国家自然科学基金（81472329、81201906）

Tumor angiogenic mechanisms of esophageal squamous cell carcinoma

Lyu Yajing, Wang Wei, Ji Chushu, Hu Bing

Department of Tumor Chemotherapy, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, China

Received:2015-11-18Online:2016-06-08Published:2016-04-27
Contact:Hu Bing E-mail:hubin3756@sina.com
Supported by:

National Natural Science Foundation of China (81472329, 81201906)

摘要/Abstract

摘要：血管内皮生长因子、缺氧诱导因子、白细胞介素、血管生成素样蛋白、整合素和上皮间质转化在食管鳞状细胞癌血管生成中为癌细胞的生长、侵袭和转移提供了营养支持和有利环境。对食管鳞状细胞癌血管生成机制的研究将为其抗血管靶向治疗提供更多思路和潜在靶点。

吕雅静，王伟，季楚舒，胡冰. 食管鳞状细胞癌的肿瘤血管生成机制[J]. 国际肿瘤学杂志, 2016, 43(6): 465-467.

Lyu Yajing, Wang Wei, Ji Chushu, Hu Bing. Tumor angiogenic mechanisms of esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2016, 43(6): 465-467.

［1］ Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma［J］. Lancet, 2013, 381(9864): 400-412. DOI: 10.1016/S0140-6736(12)60643-6. ［2］ Jubb AM, Strickland LA, Liu SD, et al. Neuropilin1 expression in cancer and development［J］. J Pathol, 2012, 226(1): 50-60. DOI: 10.1002/path.2989. ［3］ Bumbaca D, Xiang H, Boswell CA, et al. Maximizing tumour exposure to antineuropilin1 antibody requires saturation of nontumour tissue antigenic sinks in mice［J］. Br J Pharmacol, 2012, 166(1): 368-377. DOI: 10.1111/j.1476-5381.2011.01777.x. ［4］ Nomiya T, Nemoto K, Miyachi H, et al. Relationships between radiosensitivity and microvascular density in esophageal carcinoma: significance of hypoxic fraction［J］. Int J Radiat Oncol Biol Phys, 2004, 58(2): 589-596. DOI: 10.1016/j.ijrobp.2003.09.037. ［5］ Qasim I, Bhat IA, Masoodi KZ, et al. Role of +405C>G and+936C>T polymorphisms of the vascular endothelial growth factor gene and risk of esophageal cancer in the kashmiri population［J］. Asian Pac J Cancer Prev, 2015, 16(1): 97-101. ［6］ Yang PW, Hsieh MS, Huang YC, et al. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma［J］. PLoS One, 2014, 9(6): e100326. DOI: 10.1371/journal.pone.0100326. ［7］ Sui WW, Zhang WD. Research of hypoxiainducible factor in tumor angiogenesis［J］. J Int Oncol, 2013, 40(6): 416-418. ［8］ Jing SW, Wang YD, Chen LQ, et al. Hypoxia supresses Ecadherin and enhances matrix metalloproteinase2 expression favoring esophageal carcinoma migeration and invasion via hypoxia induced factoralpha activation［J］. Dis Esophagus, 2013, 26(1): 75-83. ［9］ Tang NN, Zhu H, Zhang HJ, et al. HIF1 alpha induces VEcadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells［J］. World J Gastroenterol, 2014, 20(47): 17894-17904. DOI: 10.3748/wjg.v20.i47.17894. ［10］ Li Y, Fu L, Li JB, et al. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma［J］. Gastroenterology, 2014, 146(7): 1701. DOI: 10.1053/j.gastro.2014.02.029. ［11］ Dang K, Myers KA. The role of hypoxiainduced miRNA210 in cancer progression［J］. Int J Mol Sci, 2015, 16(3): 6353-6372. ［12］ Chen DY, Li W, Liu SZ, et al. Interleukin23 promotes the epithelialmesenchymal transition of oesophageal carcinoma cells via the Wnt/betacatenin pathway［J］. Sci Rep, 2015, 5: 8604. DOI: 10.1038/srep08604. ［13］ Chen MF, Chen PT, Lu MS, et al. IL6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus［J］. Mol Cancer, 2013, 12: 26. DOI: 10.1186/14764598-12-26. ［14］ Ide S, Toiyama Y, Shimura T, et al. Angiopoietinlike protein 2 acts as a novel biomarker for diagnosis and prognosis in patients with esophageal cancer［J］. Ann Surg Oncol, 2015, 22(8): 2585-2592. DOI: 10.1245/s10434-014-4315-0. ［15］ Shibata K, Nakayama T, Hirakawa HA, et al. Clinicopathological significance of angiopoietinlike protein 4 expression in oesophageal squamous cell carcinoma［J］. J Clin Pathol, 2010, 63(12): 1054-1058. DOI: 10.1136/jcp.2010.078600. ［16］ Ravelli C, Mitola S, Corsini M, et al. Involvement of alpha(v)beta(3) integrin in gremlininduced angiogenesis［J］. Angiogenesis, 2013, 16(1): 235-243. DOI: 10.1007/s10456-012-9309-6. ［17］ Tong M, Chan KW, Bao JY, et al. Rab25 is a tumor suppressor gene with antiangiogenic and antiinvasive activities in esophageal squamous cell carcinoma［J］. Cancer Res, 2012, 72(22): 60246035. DOI: 10.1158/00085472.CAN121269. ［18］ Yoshida R, Morita M, Shoji F, et al. Clinical significance of SIP1 and ecadherin in patients with esophageal squamous cell carcinoma［J］. Ann Surg Oncol, 2015, 22(8): 2608-2614. DOI: 10.1245/s10434-014-4314-1. ［19］ Liu J, Chen L, Deng H, et al. Epithelialtomesenchymal transition in human esophageal cancer associates with tumor progression and patient′s survival［J］. Int J Clin Exp Pathol, 2014, 7(10): 6943-6949. ［20］ Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGFbeta promotes the invasionmetastasis cascade in hepatocellular carcinoma［J］. Cancer Cell, 2014, 25(5): 666-681. DOI: 10.1016/j.ccr.2014.03.010. ［21］ Wang N, Liu F, Cao F, et al. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelialmesenchymal transition［J］. Cancer Biol Ther, 2015, 16(4): 528-540. DOI: 10.1080/15384047.2015.1016687. ［22］ Song Y, Li J, Zhu Y, et al. MicroRNA9 promotes tumor metastasis via repressing Ecadherin in esophageal squamous cell carcinoma［J］. Oncotarget, 2014, 5(22): 11669-11680. DOI: 10.18632/oncotarget.2581. ［23］ Li W, Jiang G, Zhou J, et al. Downregulation of miR140 induces EMT and promotes invasion by targeting Slug in esophageal cancer［J］. Cell Physiol Biochem, 2014, 34(5): 1466-1476. DOI: 10.1159/000366351. ［24］ Zhang Y, Pan T, Zhong X, et al. Nicotine upregulates microRNA-21 and promotes TGF-βdependent epithelialmesenchymal transition of esophageal cancer cells［J］. Tumour Biol, 2014, 35(7): 7063-7072. DOI: 10.1007/s13277-014-1968-z.

[1]	钱晓涛, 石子宜, 胡格, 吴晓维.Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[4]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[5]	范志鹏, 余静, 胡静, 廖正凯, 徐禹, 欧阳雯, 谢丛华.炎症标志物的变化趋势对一线接受免疫联合化疗的晚期非小细胞肺癌患者预后的预测价值[J]. 国际肿瘤学杂志, 2024, 51(5): 257-266.
[6]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[7]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[8]	顾芳萌, 徐晨阳, 雷大鹏.人工智能辅助电子喉镜检查在喉癌及喉癌前病变诊治中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(5): 303-307.
[9]	张文馨, 夏泠, 彭晋, 周福祥.甲胎蛋白升高型胃肝样腺癌1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(5): 312-315.
[10]	王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[11]	万芳, 杨钢, 李睿, 万启晶.食管癌患者血清miR-497、miR-383水平及临床意义[J]. 国际肿瘤学杂志, 2024, 51(4): 204-209.
[12]	杨毫, 施贵冬, 张程城, 张跃, 张力文, 付茂勇.信迪利单抗与替雷利珠单抗在进展期食管鳞状细胞癌新辅助治疗中的疗效及安全性对比[J]. 国际肿瘤学杂志, 2024, 51(4): 210-216.
[13]	姚益新, 沈煜霖.血清SOCS3、TXNIP水平对肝细胞癌TACE治疗预后的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 217-222.
[14]	胡婷婷, 王越华.电子鼻与线虫鼻——新型早期癌症筛查工具[J]. 国际肿瘤学杂志, 2024, 51(4): 223-226.
[15]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛.索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.